HERBALIFE LTD. (HLF) Operating Margin
- Operating margin · 12 months: Value 9.47%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.47% | Operating income / revenue. Period ending 2026-06-30. $492.30M ÷ $5.20B × 100 ≈ 9.47% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 492.30M USD | Operating Income (Loss) |
| Revenue | 5.20B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.16B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $492.30M | $5.20B | $1.16B | (m) | (m) | 9.47% |
| 2026-03-31 | $496.60M | $5.13B | $1.14B | (m) | (m) | 9.67% |
| 2025-12-31 | $481.00M | $5.04B | $1.11B | (m) | (m) | 9.55% |
| 2025-09-30 | $487.70M | $4.96B | $1.09B | (m) | $1.76B | 9.83% |
| 2025-06-30 | $489.00M | $4.93B | $1.08B | (m) | $1.76B | 9.92% |
| 2025-03-31 | $436.80M | $4.95B | $1.08B | (m) | $1.82B | 8.82% |
| 2024-12-31 | $385.90M | $4.99B | $1.10B | (m) | $1.88B | 7.73% |
| 2024-09-30 | $335.20M | $5.00B | $1.12B | (m) | $1.91B | 6.70% |
| 2024-06-30 | $314.80M | $5.04B | $1.16B | (m) | $1.92B | 6.24% |
| 2024-03-31 | $357.80M | $5.07B | $1.18B | (m) | $1.88B | 7.05% |
| 2023-12-31 | $356.40M | $5.06B | $1.19B | (m) | $1.87B | 7.04% |
| 2023-09-30 | $389.50M | $5.03B | $1.17B | (m) | $1.83B | 7.75% |
| 2023-06-30 | $430.20M | $5.04B | $1.15B | (m) | $1.82B | 8.53% |
| 2023-03-31 | $462.60M | $5.12B | $1.17B | (m) | $1.83B | 9.03% |
| 2022-12-31 | $545.20M | $5.20B | $1.17B | (m) | $1.81B | 10.48% |
| 2022-09-30 | $540.60M | $5.34B | $1.20B | (m) | $1.89B | 10.12% |
| 2022-06-30 | $582.60M | $5.48B | $1.22B | (m) | $1.92B | 10.64% |
| 2022-03-31 | $664.70M | $5.64B | $1.23B | (m) | $1.96B | 11.79% |
| 2021-12-31 | $734.10M | $5.80B | $1.24B | (m) | $2.01B | 12.65% |
| 2021-09-30 | $798.20M | $5.90B | $1.25B | (m) | $2.01B | 13.54% |
| 2021-06-30 | $815.70M | $5.99B | $1.27B | (m) | $2.06B | 13.63% |
| 2021-03-31 | $767.50M | $5.78B | $1.22B | (m) | $2.03B | 13.28% |
| 2020-12-31 | $640.60M | $5.54B | $1.15B | (m) | $2.08B | 11.56% |
| 2020-09-30 | $600.60M | $5.35B | $1.07B | (m) | $2.09B | 11.22% |
| 2020-06-30 | $537.30M | $5.07B | $991.70M | (m) | $2.06B | 10.59% |
| 2020-03-31 | $500.70M | $4.97B | $962.10M | (m) | $2.05B | 10.08% |
| 2019-12-31 | $568.10M | $4.88B | $958.00M | (m) | $1.94B | 11.65% |
| 2019-09-30 | $607.90M | $4.84B | $954.10M | (m) | $1.90B | 12.55% |
| 2019-06-30 | $651.60M | $4.84B | $928.80M | (m) | $1.90B | 13.46% |
| 2019-03-31 | $690.30M | $4.89B | $921.00M | (m) | $1.93B | 14.12% |
| 2018-12-31 | $683.10M | $4.89B | $919.30M | (m) | $1.96B | 13.96% |
| 2018-09-30 | $684.00M | $4.80B | $903.20M | (m) | $1.90B | 14.25% |
| 2018-06-30 | $616.00M | $4.64B | $900.50M | (m) | $1.85B | 13.27% |
| 2018-03-31 | $629.10M | $4.50B | $883.90M | (m) | $1.78B | 13.97% |
| 2017-12-31 | $617.10M | $4.43B | $848.60M | (m) | $1.76B | 13.94% |
| 2017-09-30 | $626.20M | $4.38B | $834.90M | (m) | $1.75B | 14.30% |
| 2017-06-30 | $658.40M | $4.42B | $828.60M | (m) | $1.74B | 14.91% |
| 2017-03-31 | $433.60M | $4.47B | $846.10M | (m) | $1.98B | 9.70% |
| 2016-12-31 | $458.10M | $4.49B | $854.60M | (m) | $1.97B | 10.21% |
| 2016-09-30 | $442.50M | $4.54B | $862.90M | (m) | $1.99B | 9.74% |
| 2016-06-30 | $452.60M | $4.52B | $860.70M | (m) | $1.98B | 10.01% |
| 2016-03-31 | $616.30M | $4.48B | $853.70M | (m) | $1.77B | 13.75% |
| 2015-12-31 | $583.60M | $4.47B | $856.00M | (m) | $1.78B | 13.06% |
| 2015-09-30 | $603.00M | $4.50B | $871.20M | (m) | $1.75B | 13.39% |
| 2015-06-30 | $468.90M | $4.66B | $919.30M | (m) | $1.93B | 10.07% |
| 2015-03-31 | $521.60M | $4.80B | $947.10M | (m) | $1.92B | 10.86% |
| 2014-12-31 | $513.50M | $4.96B | $982.90M | (m) | $1.99B | 10.36% |
| 2014-09-30 | $533.39M | $5.09B | $1.02B | (m) | $2.03B | 10.47% |
| 2014-06-30 | $697.89M | $5.05B | $998.61M | (m) | $1.83B | 13.82% |
| 2014-03-31 | $693.96M | $4.96B | $988.61M | (m) | $1.77B | 13.98% |
| 2013-12-31 | $735.28M | $4.83B | $963.42M | (m) | $1.63B | 15.24% |
| 2013-09-30 | $713.21M | $4.62B | $922.72M | (m) | $1.51B | 15.45% |
| 2013-06-30 | $681.91M | $4.42B | $885.90M | (m) | $1.42B | 15.43% |
| 2013-03-31 | $676.26M | $4.23B | $842.42M | (m) | $1.33B | 15.98% |
| 2012-12-31 | $661.45M | $4.07B | $812.58M | (m) | $1.26B | 16.24% |
| 2012-09-30 | $636.00M | $3.90B | $772.44M | (m) | $1.21B | 16.32% |
| 2012-06-30 | $626.51M | $3.78B | $746.15M | (m) | $1.17B | 16.59% |
| 2012-03-31 | $592.98M | $3.62B | $713.43M | (m) | $1.13B | 16.36% |
| 2011-12-31 | $562.27M | $3.45B | $680.08M | (m) | $1.07B | 16.28% |
| 2011-09-30 | $534.16M | $3.31B | $657.64M | (m) | $1.03B | 16.15% |
| 2011-06-30 | $483.77M | $3.10B | $615.59M | (m) | $980.41M | 15.60% |
| 2011-03-31 | $446.95M | $2.91B | $581.13M | (m) | $925.30M | 15.36% |
| 2010-12-31 | $387.51M | $2.73B | $558.81M | (m) | $887.65M | 14.17% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $296.03M | $2.32B | $493.13M | (m) | $773.91M | 12.73% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $332.25M | $2.36B | $458.40M | (m) | $771.85M | 14.08% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |